Real-time enrollment status for this unresectable or metastatic hepatocellular carcinoma clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 11:36 AM UTC
| NCT Number | NCT07219459 |
| Recruiting Status | Recruiting |
| Condition | Unresectable or Metastatic Hepatocellular Carcinoma |
| Phase | PHASE2 |
| Target Enrollment | 104 participants |
| Active Locations | 3 sites in the US |
| Sponsor | CatalYm GmbH |
| Last Updated on CT.gov | June 24, 2026 (3 weeks ago) |
As of July 17, 2026: Clinical trial NCT07219459 is currently recruiting participants. This phase2 study for unresectable or metastatic hepatocellular carcinoma is actively seeking new participants at 3 locations across the United States. The study is sponsored by CatalYm GmbH. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07219459 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07219459 was last updated 3 weeks ago (June 24, 2026). HelloStudys verifies this status automatically.